Argon Beam Coagulation as an Adjuvant for Local Control of Giant Cell Tumor
Authors:
- Valerae O LewisVLValerae O Lewis
- Anthony WeiAWAnthony Wei
- Tito MendozaTMTito Mendoza
- Frank PrimusFPFrank Primus
- Terrance PeabodyTPTerrance Peabody
- Michael A SimonMSMichael A Simon
- 1 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 454, 192-197
Abstract
The argon beam coagulator is gaining popularity as an adjuvant therapy for treatment of giant cell tumors of bone. However, the effectiveness and functional implications of this treatment have not been assessed. To determine whether the argon beam coagulator could be a viable adjuvant treatment option, we examined the recurrence rate and functional outcome of patients with giant cell tumors who were treated with the argon beam coagulator, as an adjuvant to curettage and cementation. Thirty-seven patients who received argon beam coagulation as an adjuvant treatment for giant cell tumors diagnosed between 1993 and 2000 were identified. The median age of the patients was 32 years (range, 16-64 years). The mean followup was 73.7 months (range, 0.5-108 months). Three patients had osseous recurrences (8.3%) and one had a soft tissue recurrence. The 5-year Kaplan-Meier disease-free survival estimate was 87.2% (95% confidence interval, range, 76.3-99.8). No patient had radiographic evidence of arthritis. The average Musculoskeletal Tumor Society score was 28. Short form-36 evaluation showed no change in functional or mental perception in these patients compared with US norms. These data suggest argon beam coagulation as an adjuvant therapy is associated with in a low rate of local recurrence and is a reasonable adjuvant treatment option.Keywords
This publication has 27 references indexed in Scilit:
- Ablation of Metastatic Ovarian Carcinoma with the Argon Beam Coagulator: Pathologic Analysis of Tumor DestructionGynecologic Oncology, 2001
- Complete Surgical Cytoreduction of Advanced Ovarian Carcinoma Using the Argon Beam CoagulatorGynecologic Oncology, 2001
- Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapyEuropean Journal of Surgical Oncology, 2001
- Cryosurgery in the Treatment of Giant Cell TumorClinical Orthopaedics and Related Research, 1999
- Radiological And Clinical Recurrence Of Giant-cell Tumour Of Bone After The Use Of CementThe Journal of Bone and Joint Surgery. British volume, 1997
- Cytotoxicity of phenol to musculoskeletal tumoursThe Journal of Bone and Joint Surgery. British volume, 1996
- Thermal Aspects of the Use of Polymethylmethacrylate in Large Metaphyseal Defects in BoneClinical Orthopaedics and Related Research, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Giant Cell Tumor of BoneClinical Orthopaedics and Related Research, 1986
- Bone cement, thermal injury and the radiolucent zoneActa Orthopaedica, 1984